Moleculin Biotech MBRX
NASDAQ MBRX
$6.28 +0.09 (+1.37%)
As of: Oct 21, 2026 · 1:34 PM EDT

Moleculin Biotech (MBRX) Acquisitions (2016)

Updated

Moleculin Biotech (MBRX) reported Acquisitions of $100,000 for FY2016.

Analysis

Moleculin Biotech (MBRX) Acquisitions (2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,134.13 Bn 1,102.72 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 616.20 Bn 534.73 Bn 17.26 Bn -17.24 Bn
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn -
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn -
5 Novartis Ag 297.88 Bn 261.87 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 261.36 Bn 235.05 Bn 12.86 Bn -
7 Amgen 235.80 Bn 191.20 Bn 7.24 Bn -
8 Gilead Sciences 190.78 Bn 164.97 Bn 6.22 Bn 11.21 Bn
9 Pfizer 169.43 Bn 116.08 Bn 10.94 Bn -
10 Moleculin Biotech 35.65 Mn 5.25 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2016 100,362.00
API Access

Moleculin Biotech Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=MBRX&period=max&api_key=YOUR_API_KEY